Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zimmer Biomet Holdings, Inc. ZBH

Healthcare  —  Medical Devices
91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
S&P 500 Member Dividend Champion (10y) Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) Price to free cash flow

As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a price to free cash flow of 16.9×. Over the past ten years it has ranged from 14.5× (December 2018) to 117× (April 2021); the current reading is higher than 6% of that period. That is below the Medical Devices industry median of 22.5× and below the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 16.5× (39.70%)
FY2024 27.4× (5.29%)
FY2023 28.9× (5.42%)
FY2022 30.6× 16.34%
FY2021 26.3× (56.97%)
FY2020 61.1× 66.28%
FY2019 36.8× 134.68%
FY2018 15.7× (29.85%)
FY2017 22.3× 22.62%
FY2016 18.2× (59.45%)

Quarterly

Period Price to free cash flow Change
Jun 2026 16.0× (8.73%)
Mar 2026 17.5× 5.83%
Dec 2025 16.5× (14.35%)
Sep 2025 19.3× 10.24%
42 more quarters

Against its own ten years

Low 14.5× High 117×
Ten-year median 26.4×
Current reading's percentile 6

Price to free cash flow against peers

Company Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare 6.0×
PHG Koninklijke Philips N.V. compare 12.9×
GMED Globus Medical, Inc. compare 13.7×
ZBH Zimmer Biomet Holdings, Inc. 16.9×
GEHC GE HealthCare Technologies Inc. compare 19.1×
STE STERIS plc compare 21.8×
BIO.B Bio-Rad Laboratories, Inc. compare 27.5×
BIO Bio-Rad Laboratories, Inc. compare 28.7×
PEN Penumbra, Inc. compare 58.1×
Medical Devices industry median 22.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ZBH